Skip to main content

Table 3 Possible prognostic factors predicting probability for complete remission in 144 dogs with lymphoma

From: Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma

Variable

P-value

Higher CR probability with

Age (years)

0.004

Lower age

Gender (M/F)

0.822

 

Neutering (Y/N)

0.818

 

Weight (kg)

0.159

 

Corticosteroid pretreatment (Y/N)

0.853

 

Anatomical subtype

0.026

Multicentric lymphoma

Stage (1–5)

0.845

 

Substage

0.023

Substage a

Immunophenotype (B/T)

0.405

 

Anaemia (Y/N)

0.004

No anaemia

Hematology

  

 Hematocrit (l/l/)

0.026

Higher hematocrit

 Lymphocytes number

0.351

 

 Neutrophils number

0.101

 

 Platelets number

0.281

 

Hypercalcemia (Y/N)

0.895

 

Ultrasound spleen

0.448

 

Ultrasound liver

0.691

 

Xray size spleen (1–3)

0.008

No enlargement

Xray size liver (1–3)

0.341

 

Cytological involvement spleen (Y/N)

0.120

 

Cytological involvement liver (Y/N)

0.227

Â